GlassScriptPhysician profile
Shekar H Narayanan
NPI 1881763977
$66,934.16
in general payments reported to CMS, 2019-2025
36 companies · $17K in 2025
The $17K reported for 2025 was more than what 95% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $2,515 · 2021: $3,378 · 2022: $24K · 2023: $2,413 · 2024: $3,251 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $4,348 · Travel and Lodging: $3,580 · Education: $50.00 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,850.00 |
| Food and Beverage | $4,348.16 |
| Travel and Lodging | $3,579.61 |
| Education | $50.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $30,402.90 | 2019-2025 | Harmonic, Echelon Circular |
| Medical Device Business Services, INC. | $13,063.48 | 2019-2025 | Stratafix, Enseal X1, Dermabond Prineo |
| Ethicon INC. | $10,610.70 | 2019-2025 | Monarch Platform, Dermabond Prineo |
| Ethicon Endo-Surgery INC. | $6,075.00 | 2023-2025 | Echelon Circular |
| Intuitive Surgical, INC. | $2,630.92 | 2019-2024 | |
| Abbvie INC. | $1,610.21 | 2019-2025 | |
| Celgene Corporation | $475.99 | 2022-2024 | Zeposia |
| Janssen Biotech, INC. | $394.87 | 2024-2025 | Tremfya, Stelara, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $301.46 | 2020-2025 | Gattex, Entyvio |
| Dilon Technologies, INC. | $233.48 | 2025 | Hemoblast Bellows |
| Tela Bio, INC. | $121.61 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Axonics, INC. | $120.32 | 2023-2024 | Axonics |
| Smith+Nephew, INC. | $103.62 | 2024-2025 | Grafix Pl, Stravix Pl |
| Medtronic, INC. | $86.64 | 2022-2024 | Interstim |
| Innovation Technologies INC | $82.93 | 2023-2025 | Irrisept |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $77.67 | 2019-2025 | Sutab, Suflave |
| Lumendi LLC | $69.25 | 2019 | |
| Davol INC. | $48.88 | 2024-2025 | Arista Ah Flexitip, Arista |
| Vertex Pharmaceuticals Incorporated | $47.74 | 2025 | |
| Polynovo North America LLC | $46.60 | 2025 | Novosorb Btm |
| Baxter Healthcare | $44.71 | 2022 | |
| Kerecis Limited | $31.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Hologic Sales and Service, LLC | $27.93 | 2025 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $26.47 | 2019 | |
| Ferring Pharmaceuticals INC. | $25.77 | 2019-2023 | Rebyota |
| Micro-Tech Endoscopy USA, INC. | $24.03 | 2024 | Inflation Device |
| Shire North American Group INC | $23.59 | 2019 | |
| Boston Scientific Corporation | $18.70 | 2025 | Axonics |
| Hospira, INC. | $18.10 | 2019 | |
| Hologic INC | $16.59 | 2021 | |
| Pfizer INC. | $13.16 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.14 | 2019 | |
| Medtronic USA, INC. | $12.91 | 2019 | |
| Integra Lifesciences Corporation | $12.74 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.98 | 2020 | |
| Biocomposites INC | $8.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shekar Narayanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.